David M. Fry

Joshua I. Rothman

Jack B. Blumenfeld

Lois Kwasigroch

John D. Murnane

Maryellen Noreika

Wendy A. Whiteford

Eric Agovino

Alicia A. Rose Russo

Teva Pharmaceutical Industries Ltd

Amgen USA Inc

Amgen Inc

Teva Pharmaceuticals USA Inc

Last Docket Entry Date

Total Docket Entries

ANDA filing sparks clash: Teva’s generic SENSIPAR® accused by Amgen over a 'rapid dissolution formulation' patent key to hyperparathyroidism treatment.

1:17-cv-01809 | Amgen Inc v. Teva Pharma USA Inc | Ex Parte

United States District of Delaware

Name	Ratings
Amgen USA Inc	L4E
Amgen Inc	L4E

Name	Ratings
Morris Nichols Arsht & Tunnell LLPLocal	L5A
Jack B. Blumenfeld	L5A
Maryellen Noreika	L4A
Venable LLP	L4A
Joshua I. Rothman	L5A
Alicia A. Rose Russo	L4B
Fitzpatrick Cella Harper & Scinto	L4A
John D. Murnane	L4A
Amgen Inc	L1C
Eric Agovino	L5C
Wendy A. Whiteford	L4A
Lois Kwasigroch	L4C

Name	Ratings
Teva Pharmaceuticals USA Inc	L5E
Teva Pharmaceutical Industries Ltd	L5E

Name	Ratings
Jpmorgan Chase	---- --
David M. Fry	---- --